Health Canada’s ongoing delay tactics hint at AstraZeneca vaccine scandal
Canada’s health regulator’s delays in addressing an ATIP request about 1.5 million AstraZeneca vaccine doses from a contaminated U.S. facility signal a lack of transparency, hinting at reliance on corporate data rather than independent oversight.